It has been found that TOPK can facilitate the occurrence and development of tumors (e.g., ovarian cancer, malignant glioma, colonic cancer and non-small-cell lung carcinoma) by promoting their growth, invasion and metastasis (18–21), thus it is regarded as a new target for tumor-specific therapy. The gene discussed is PBK; the disease is malignant colon neoplasm.